Literature DB >> 8841701

Speech-perception performance in prelingually deafened French children using the nucleus multichannel cochlear implant.

A S Uziel1, F Reuillard-Artieres, M Sillon, A Vieu, M Mondain, J P Piron, E A Tobey.   

Abstract

PURPOSE: The speech-perception abilities of 36 French children, whose onset of deafness occurred before 2 years of age, was longitudinally examined after they received a Nucleus multichannel cochlear implant.
METHODS: Speech perception was assessed in four areas: phoneme detection, closed-set word and sentence recognition; and modified open-set recognition.
RESULTS: All children achieved phoneme detection by 3 months after implantation. Closed-set word and sentence recognition appeared initially less accurate in children with congenital deafness than in the prelingually deafened children; however, these differences disappeared by 18 months after implantation. Some modified open-set recognition was evident by 12 months after implantation and continued to improve 3 years after implantation.
CONCLUSIONS: Data demonstrate significant improvements in speech perception with implant experience: 15 (60%) of 25 of the children identified sentences in closed sets, 22 (88%) of 25 identified words in closed sets after 12 months' experience, and 13 (81%) of 16 demonstrated open-set recognition after 24 months of implant use.

Entities:  

Mesh:

Year:  1996        PMID: 8841701

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  2 in total

1.  Mandarin Chinese speech recognition by pediatric cochlear implant users.

Authors:  Meimei Zhu; Qian-Jie Fu; John J Galvin; Ye Jiang; Jianghong Xu; Chenmei Xu; Duoduo Tao; Bing Chen
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2011-04-12       Impact factor: 1.675

2.  Speech development in children after cochlear implantation.

Authors:  Mehdi Bakhshaee; Mohammad Mahdi Ghasemi; Mohammad Taghi Shakeri; Narjes Razmara; Hamid Tayarani; Mohammad Reza Tale
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-17       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.